| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:scph | nasdaq:scph Shareholders | 13F-HR/A | 0001166588-22-000018 | Mar 31st, 2022 12:00AM | May 18th, 2022 12:00AM | May 18th, 2022 12:00AM | BNP PARIBAS ARBITRAGE, SA | 1166588 | scPharmaceuticals Inc | Equity | 810648105 | 602 | 106 | SH | DFND | 1 | 0 | 106 | 0 | May 19th, 2022 01:12AM | May 19th, 2022 01:12AM | scPharmaceuticals | |||
| nasdaq:scph | nasdaq:scph Shareholders | 13F-HR | 0001754001-22-000005 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Worth Venture Partners, LLC | 1696778 | SCPHARMACEUTICALS INC | COM | 810648105 | 1979 | 348425 | SH | OTR | 2 | 0 | 348425 | 0 | May 17th, 2022 01:58AM | May 17th, 2022 01:58AM | scPharmaceuticals | |||
| nasdaq:scph | nasdaq:scph Shareholders | 13F-HR | 0001567619-22-010852 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | ROYAL BANK OF CANADA | 1000275 | SCPHARMACEUTICALS INC | COM | 810648105 | 0 | 56 | SH | DFND | 2 | 56 | 0 | 0 | May 17th, 2022 01:55AM | May 17th, 2022 01:55AM | scPharmaceuticals | |||
| nasdaq:scph | nasdaq:scph Shareholders | 13F-HR | 0001567619-22-010822 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | BANK OF AMERICA CORP /DE/ | 70858 | SCPHARMACEUTICALS INC | COM | 810648105 | 0 | 39 | SH | DFND | 03 | 0 | 39 | 0 | May 17th, 2022 01:54AM | May 17th, 2022 01:54AM | scPharmaceuticals | |||
| nasdaq:scph | nasdaq:scph Shareholders | 13F-HR | 0001567619-22-010822 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | BANK OF AMERICA CORP /DE/ | 70858 | SCPHARMACEUTICALS INC | COM | 810648105 | 6 | 1000 | SH | DFND | 02 | 0 | 0 | 1000 | May 17th, 2022 01:54AM | May 17th, 2022 01:54AM | scPharmaceuticals | |||
| nasdaq:scph | nasdaq:scph Shareholders | 13F-HR | 0001493152-22-013621 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | BOOTHBAY FUND MANAGEMENT, LLC | 1549230 | SCPHARMACEUTICALS INC | COM | 810648105 | 492 | 86635 | SH | OTR | 0 | 86635 | 0 | May 17th, 2022 01:52AM | May 17th, 2022 01:52AM | scPharmaceuticals | ||||
| nasdaq:scph | nasdaq:scph Shareholders | 13F-HR | 0001446194-22-000004 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1446194 | SCPHARMACEUTICALS INC | COM | 810648105 | 231 | 40689 | SH | DFND | 2 | 40689 | 0 | 0 | May 17th, 2022 01:51AM | May 17th, 2022 01:51AM | scPharmaceuticals | |||
| nasdaq:scph | nasdaq:scph Shareholders | 13F-HR | 0001172661-22-001456 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | ORBIMED ADVISORS LLC | 1055951 | SCPHARMACEUTICALS INC | COM | 810648105 | 27248 | 4797148 | SH | SOLE | 4797148 | 0 | 0 | May 17th, 2022 01:47AM | May 17th, 2022 01:47AM | scPharmaceuticals | ||||
| nasdaq:scph | nasdaq:scph Shareholders | 13F-HR | 0001104659-22-061386 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | RA CAPITAL MANAGEMENT, L.P. | 1346824 | SCPHARMACEUTICALS INC | COM | 810648105 | 15101 | 2658583 | SH | SOLE | 2658583 | 0 | 0 | May 17th, 2022 01:46AM | May 17th, 2022 01:46AM | scPharmaceuticals | ||||
| nasdaq:scph | nasdaq:scph Shareholders | 13F-HR | 0001104659-22-061252 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | 5AM Venture Management, LLC | 1799883 | SCPHARMACEUTICALS INC | COM | 810648105 | 21763 | 3831474 | SH | SOLE | 3831474 | 0 | 0 | May 17th, 2022 01:45AM | May 17th, 2022 01:45AM | scPharmaceuticals |